Acorda Therapeutics (ACOR) Reports Q4 Loss of $0.67
Tweet
Share
E-mail
Get Alerts ACOR Hot Sheet
Price: $0.66 --0%
Financial Fact:
Research and development: 54.78M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Financial Fact:
Research and development: 54.78M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Acorda Therapeutics (NASDAQ: ACOR) reported Q4 EPS of ($0.67), versus ($2.50) reported last year. Revenue for the quarter came in at $36.97 million versus the consensus estimate of $31.01 million.
For earnings history and earnings-related data on Acorda Therapeutics (ACOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global completes sale of energy software portfolio to SLB
- Medtronic jumps on earnings beat and raised guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
